Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-301-8233
Education & Training
- Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2002 - 2005
- California Pacific Medical CenterResidency, Internal Medicine, 1998 - 2002
- University of Tennessee Health Science Center College of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 1999 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
Clinical Trials
- Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2003 Dec 22
- Dasatinib in Treating Patients With Stage IV Pancreatic Cancer Start of enrollment: 2007 Sep 01
- Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.Erkut H Borazanci, Nathan Bahary, Vincent Chung, Timothy K Huyck, Ebenezer A Kio
The Oncologist. 2024-11-04 - 1 citationsDKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish.Samuel J Klempner, Mohamad Bassam Sonbol, Zev A Wainberg, Hope Elizabeth Uronis, Vi K Chiu
Journal of Clinical Oncology. 2024-10-21 - 3 citationsOutcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.Enrique Soto-Perez-de-Celis, William Dale, Vani Katheria, Heeyoung Kim, Marwan Fakih
Cancer. 2024-09-01
Lectures
- Gene expression profiling of unresectable pancreatic cancer patients treated with gemcitabine, nab-paclitaxel, metformin, and dietary supplements (DS).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- First-time in-human study of VMD-928, an allosteric and irreversible TrkA selective inhibitor, in patients with solid tumors or lymphoma.2019 ASCO Annual Meeting - 6/1/2019
- A SU2C catalyst randomized phase II trial of pembrolizumab with or without paricalcitol in patients with stage IV pancreatic cancer who have been placed in best possib...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
- First Patient Has Received Novel, Potentially Cancer-Stopping PillOctober 19th, 2022
- Adding Dietary Supplements to Treatment Impacts Outcomes in Unresectable Pancreatic CancerJanuary 25th, 2020
- Dr. Chung on the COMPASS Trial in Pancreatic CancerFebruary 28th, 2019
- Join now to see all
Committees
- Member, Pancreatic Cancer Research Team
- Member, Institutional Review Board
- Member, SWOG
- Member, California Cancer Consortium
Professional Memberships
- Member
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: